Akèy › Ensifizans renn › New York
Etid klinik pou Ensifizans renn nan New York
16 etid pou Ensifizans renn ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- Roswell Park Comprehensive, Buffalo
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05287945Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Albany Medical College Committee of Research Involving Human Subjects, Albany
- SUNY Downstate Medical Center Brooklyn, Brooklyn
- Mattoo & Bhat Medical Associates, P.C., College Point
- ak 3 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
- New York University Langone Health, New York
Ap rekriteFaz 1/2
Laj 40 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT07224763Pivotal Study of the Velocity™ pAVF System
- Staten Island University Hospital Northwell Health, Staten Island
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07153939Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05465044A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
- Research Site, Ridgewood
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Aug 14, 2026 · NCT06749457Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- Albany Medical Center, Albany
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT04634916Incremental Hemodialysis: The TwoPlus Trial
- Renal Research Institute (RRI), New York
- Northwell Health, Queens
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05828823Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
- New York Kidney Hypertension Medicine, New Hyde Park
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jul 6, 2026 · NCT06613568Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
- Northwell Health, New Hyde Park
Ap rekrite
Laj 18 a 84 · Tout sèks · Mizajou Apr 13, 2026 · NCT06190717Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
- New York University Langone Health, New York
Ap rekriteFaz 1/2
Laj 40 a 70 · Tout sèks · Mizajou Mar 27, 2026 · NCT06878560Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- SUNY Upstate Medical University, Syracuse
- Albert Einstein College of Medicine / Montefiore Medical Center, The Bronx
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06217302SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Northwell Health, Lake Success
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT06001827A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Mount Sinai Hospital, New York
- Northwell Health, New York
- Montefiore Medical Center, The Bronx
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Dec 22, 2025 · NCT04671771Safety and Efficacy of Empagliflozin in Hemodialysis
- NYU Langone Health, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 4, 2025 · NCT05786443Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
- The Rogosin Institute, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 4, 2025 · NCT01802034Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.